MedTrace Logo

Long-term Effects of Breast Cancer Treatment

NCT03877029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4487

Last updated 2026-03-09

No results posted yet for this study

Summary

The objective of this project is to generate evidence about quality of life related to side effects of treatment of women with screen-detected versus symptomatic breast cancer. The project will investigate the impact of detection mode (by screening or by symptoms) versus tumor characteristics as a predictor of quality of life among breast cancer survivors. The burden of long-term effects, measured as quality of life at specific points after diagnosis, will be compared between these groups. The results will also be compared with a control group of women, who have attended screening, but never been diagnosed with breast cancer.

Conditions

Sponsors & Collaborators

  • The Dam Foundation

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Solveig Hofvind, PhD · Norwegian Institute of Public Health

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-23
Primary Completion
2024-11-13
Completion
2025-12-15

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03877029 on ClinicalTrials.gov